ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Committee Provides Increase To DOD Program

August 1, 1997

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

May 27, 1977

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Also In This 12-page Issue: NCI To Cut Budgets For New Grants By 29 Percent. R01s To Be Funded At 11th Percentile.

February 3, 2006